JPH02143156A - Transfer sheet for pattern of electrophoresis fractionation - Google Patents

Transfer sheet for pattern of electrophoresis fractionation

Info

Publication number
JPH02143156A
JPH02143156A JP63297721A JP29772188A JPH02143156A JP H02143156 A JPH02143156 A JP H02143156A JP 63297721 A JP63297721 A JP 63297721A JP 29772188 A JP29772188 A JP 29772188A JP H02143156 A JPH02143156 A JP H02143156A
Authority
JP
Japan
Prior art keywords
transfer sheet
dye
fractionation
hydrophilic
effect body
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP63297721A
Other languages
Japanese (ja)
Inventor
Mikio Kamiyama
幹夫 神山
Masahiko Yamazaki
山崎 誠彦
Kenichiro Okaniwa
憲一郎 岡庭
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Konica Minolta Inc
Original Assignee
Konica Minolta Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Konica Minolta Inc filed Critical Konica Minolta Inc
Priority to JP63297721A priority Critical patent/JPH02143156A/en
Publication of JPH02143156A publication Critical patent/JPH02143156A/en
Pending legal-status Critical Current

Links

Landscapes

  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

PURPOSE:To obtain the sheet which transfers distinct and stable component fractionation spectra from electrophoresis fractionation patterns by providing one layer of a hydrophilic colloidal layer contg. a dye precursor and dye forming effect body on a liquid impermeable base. CONSTITUTION:The development medium to be deposited with the specific component fractionation is itself hydrophilic or is uniformly coated with a hydrophilic binder. The transfer sheet is also formed by coating the hydrophilic binder with the dye precursor (chromogen) and the dye forming effect body. The effect body presenting H2O2 is used for the dye forming effect and the chromogen forms the dye cooperatively with the effect body independently or together with the other compd. in the presence of the H2O2. The transfer sheet base is colorless or white and the binder for the development medium and the transfer sheet is so selected as not to hinder the peeling after the surface contact. The electrophoresis fractionation pattern of the specific component is formed on the development medium by this constitution to trigger the reaction combination on the medium and/or the transfer sheet by which the regular dye images are formed on the transfer sheet making the surface contact. The distinct and stable images are thus obtd.

Description

【発明の詳細な説明】 〔産業上の利用分野〕 本発明は生物由来の被検体の電気泳動分画パターンによ
る解析に関し、具体的には電気泳動分画パターンの転写
・記録に関する。
DETAILED DESCRIPTION OF THE INVENTION [Industrial Application Field] The present invention relates to the analysis of biologically derived specimens using electrophoretic fractionation patterns, and specifically relates to the transcription and recording of electrophoretic fractionation patterns.

〔発明の背景〕[Background of the invention]

電気泳動法が生物由来の被検体の解析に用いられるよう
になったのは、チセリウス(Ti5elius)装置に
よる泳動分画パターンと臨床学的現象との関心が認めら
れたことに始まるが、既に被検体中の特定成分を特異的
、選択的に検出、定量し解析する手段として別途発展し
ている分析素子とは異った解析態様をなし、被検体中の
着目すべき成分を分画として展開し、病状等の変化と照
合、検討しうる電気泳動法は臨床学的研究の成果の蓄積
と共に益々重要度を高めている。
Electrophoresis began to be used for the analysis of specimens of biological origin when interest was recognized in the electrophoretic fraction patterns of the Ti5elius apparatus and clinical phenomena. It has a different analysis mode from analytical elements that have been developed separately as a means of specifically and selectively detecting, quantifying, and analyzing specific components in a specimen, and develops the components of interest in a specimen as a fraction. However, electrophoresis, which allows for comparison and examination of changes in medical conditions, is becoming increasingly important as clinical research results accumulate.

現在臨床学的解析に用いられている方法は、ゾーン電気
泳動法であって、装置が簡単、廉価でありしかも微量試
料にも適応できるので臨床的解析には打って付けの方法
である。
The method currently used for clinical analysis is zone electrophoresis, which is an ideal method for clinical analysis because it uses simple equipment, is inexpensive, and can be applied to minute samples.

被検体試料を電気泳動によって分画に展開する展開媒体
としては初期には濾紙が専ら用いられていたが、形成し
た電気泳動担体の電場方向外への液の拡散、或は液の対
流のない、澱粉、寒天、セルロースアセテート、ポリア
クリルアミド等のゲルフィルムが用いられるようになっ
ている。
In the early days, filter paper was used exclusively as a developing medium for developing the analyte sample into fractions by electrophoresis, but it is important to note that there is no diffusion of the liquid in the direction of the electric field of the formed electrophoretic carrier, or no convection of the liquid. , starch, agar, cellulose acetate, polyacrylamide, and other gel films have come to be used.

展開された分画成分の検索と定量には、分画の展開位置
と共に抽出法、形状による判定法、面積法或は発色法等
が用いられる。
To search and quantify the developed fractional components, an extraction method, a determination method based on shape, an area method, a color method, etc. are used in addition to the developed position of the fraction.

このうち発色法は、展開媒体、例えばアガロースフィル
ム上に生起させた酵素反応を4−アミノアンチピリンで
発色させる方法や更に褪色性の少いジホルマザン染色法
等が開示され、鮮明な分画パターンによって迅速、確実
に診断が下されることから多くの注目を集めている。
Among these methods, color development methods include a method in which an enzymatic reaction caused on a developing medium such as an agarose film is colored with 4-aminoantipyrine, and a diformazane staining method with less fading property, etc. , is attracting a lot of attention because it allows a reliable diagnosis.

しかし未だ満足されるレベルにはなく、更に高い発色濃
度、濃度判定においてノイズを測り込まない色調域、分
画パターンをカラー写真等に焼付けられること、展開媒
体に汚染のないこと、色素前駆体がロイコタイプで、発
色と同時に離溶、不活性な色素を形成し、展開媒体に後
処理を施す場合にも分画パターンに崩れがないことが要
望され更に展開媒体に保存強度(耐毀損性)がある、こ
と、保管に便利であること等数多くの解決すべき問題が
残されている。
However, it is still not at a satisfactory level, and requires higher color density, a tone range that does not include noise in density determination, the ability to print fractional patterns on color photographs, etc., no contamination of the developing medium, and dye precursors. It is a leuco type, which dissolves at the same time as coloring, forming an inert pigment, and it is desired that the fractionation pattern does not collapse even when the developing medium is subjected to post-treatment, and the developing medium also has storage strength (damage resistance). Many problems remain to be solved, such as availability, convenience in storage, etc.

〔発明の目的〕[Purpose of the invention]

本発明は前記展開媒体にまつわる不都合を回避し、想を
換えて分画成分を展開媒体より転写し、展開媒体に基く
支障から離脱する方法を選び、本発明の目的は、使用す
る色素前駆体に制約されることなく電気泳動分画パター
ンから転写した鮮明、安定な成分分画スペクトルを質的
にも強度的にも保存性よく記録する電気泳動分画パター
ン転写シートを提供することにある。
The present invention avoids the inconveniences associated with the developing medium, and instead chooses a method in which the fractionated components are transferred from the developing medium to avoid the problems caused by the developing medium. To provide an electrophoretic fraction pattern transfer sheet capable of recording clear and stable component fraction spectra transferred from an electrophoretic fraction pattern without any restrictions and with good preservation in terms of quality and intensity.

尚本発明においては混乱を避けるために展開媒体に形成
された分画の形状を分画パターン、転写シートに転写形
成されたものを分画スペクトルと呼ぶ。
In the present invention, to avoid confusion, the shape of the fraction formed on the development medium is called a fraction pattern, and the shape transferred and formed on the transfer sheet is called a fraction spectrum.

〔発明の構成及び作用効果〕[Structure and effects of the invention]

前記した本発明の目的は、電気泳動分画パターンを転写
・記録するシステムにおいて、液不透性支持体上に、少
なくとも色素前駆体及び色素生成作用体を含む親水性コ
ロイド層を少なくとも1層設けた転写シートによって達
成される。
The object of the present invention described above is to provide a system for transferring and recording electrophoretic fractionation patterns, in which at least one hydrophilic colloid layer containing at least a dye precursor and a dye-forming agent is provided on a liquid-impermeable support. This is achieved by using a transfer sheet.

本発明においては、特定成分分画を担持させる展開媒体
は、それ自身親水性を有する支持体、もしくは支持体上
に親水性を有するバインダを均一に塗設したものである
In the present invention, the developing medium on which the specific component fraction is supported is a support that itself has hydrophilic properties, or a support that has a hydrophilic binder uniformly coated on the support.

展開媒体に接面させる転写シートも、同様に親水性を有
するバインダに色素前駆体(色原体)及び色素生成作用
体を含有させて塗設した構成がらなっている。
The transfer sheet that is brought into contact with the developing medium is similarly coated with a hydrophilic binder containing a dye precursor (chromogen) and a dye-forming agent.

本発明に係る色原体は、非拡散性であごとが好ましく、
カラー写真に用いられるカプラーのように色原体にバラ
スト基を有して耐拡散性であっても導 よいし、また媒染層を設けて不動化されていてもよい。
The chromogen according to the present invention is preferably non-diffusible and has a chin,
The chromogen may have a ballast group to provide diffusion resistance, such as couplers used in color photography, or it may be immobilized by providing a mordant layer.

前記の色素生成よって前記バラスト基或は媒染層への結
合性は一般に失われることはなく、生成色素が拡散して
展開媒体の分画パターンに正則に対応した分画スペクト
ルの色素像が崩れることはない。
Due to the formation of the dye, the bonding property to the ballast group or mordant layer is generally not lost, and the dye image formed in the fractionation spectrum that regularly corresponds to the fractionation pattern of the developing medium is disrupted due to the formation of the dye. There isn't.

また展開媒体中の特定成分と転写シート中の色原体の間
に反応を惹起、連結する色素生成作用体は、親水性を有
するバインダの中を自由に移動できる少分子量物質であ
って、酵素、酸化還元物質、酵素反応で生ずる過酸化水
素や写真用カプラーの発色現像で生ずる発色現像剤の酸
化体のような反応を進行させる物質(作用素)の1つ1
つ、またはそれらの複合群である。即ち、特定成分に基
いて生じた一次反応を、或は更に二次反応、三次反応等
を経て色原体を酸化もしくはカップリング等によって発
色反応へ導き連結するものである。
In addition, the dye-forming agent that causes a reaction and links the specific component in the developing medium and the chromogen in the transfer sheet is a low molecular weight substance that can move freely in the hydrophilic binder, and is an enzyme. , redox substances, hydrogen peroxide produced in enzymatic reactions, and oxidized products of color developers produced in the color development of photographic couplers.
or a complex group thereof. That is, the chromogen is guided and linked to a color-forming reaction by oxidation or coupling through a primary reaction that occurs based on a specific component, or through a secondary reaction, a tertiary reaction, or the like.

転写シートの支持体は、測定ノイズを考慮して、透過光
測定用には透明色例えば無色、反射光測定用には好まし
い素地色例えば白色に整えられる。
Taking measurement noise into consideration, the support of the transfer sheet is prepared in a transparent color, such as colorless, for transmitted light measurement, and in a preferable base color, such as white, for reflected light measurement.

更に肝要なことは展開媒体バインダと転写シートバイン
ダは、接面後剥離支障を起すことなく完全、円滑な剥離
が可能なように、互に相溶性もしくは接着性の乏しいバ
インダ組合せ(例えばゼラチンと寒天等)を選定するか
、少くともいづれか一方の面に透液性の剥離層が設けら
れる。
What is more important is that the developing medium binder and transfer sheet binder should be a combination of binders that are mutually compatible or have poor adhesion (for example, gelatin and agar) so that complete and smooth peeling can be achieved without causing peeling problems after contact. etc.), or a liquid-permeable release layer is provided on at least one side.

本発明は展開媒体及び転写シートを用い、展開媒体に特
定成分の電気泳動分画パターンを生ぜしめ、展開媒体及
び/又は転写シートに前記反応連結を起動し、両者を接
面し、転写シートに正則色素像を形成せしめる。
The present invention uses a developing medium and a transfer sheet, generates an electrophoretic fractionation pattern of a specific component in the developing medium, activates the reaction linkage in the developing medium and/or the transfer sheet, brings them into contact with each other, and applies the electrophoretic fraction pattern to the transfer sheet. A regular dye image is formed.

尚両媒体は特定成分51に最適に構成することもできる
し、全成分の同時検知反応可能に構成することもできる
Both media can be configured to be optimal for the specific component 51, or can be configured to allow simultaneous detection and reaction of all components.

次に本発明を酸化酵素系に適用する例を次に示す。Next, an example in which the present invention is applied to an oxidase system will be shown below.

コレステロール コレステロールエステラーゼ コレステロールエステル         コレステロ
ール+脂肪酸トリグリセリド リボプロティンリパーゼ トリグリセリド+3 H,Oグリセロール+3脂肪酸2
HtOz十色原体 OD 色素+4 H,0 ・ホスフオリビッド ホスフオリヒ“ラド ネスフオリバーゼD コリン 0D 2HzCh十色原体           色素+4H
20本発明に係る色原体としては、過酸化水素/POD
発色系では疎水性のものが良い。
Cholesterol Cholesterol Esterase Cholesterol Ester Cholesterol + Fatty Acid Triglyceride Riboprotein Lipase Triglyceride + 3 H, O Glycerol + 3 Fatty Acid 2
HtOz Decachrogen OD Pigment +4 H,0 ・Phospholibid Phosphorihi "Radonesfoolivase D Choline 0D 2HzCh Decachrogen Dye +4H
20 As the chromogen according to the present invention, hydrogen peroxide/POD
For coloring systems, hydrophobic ones are best.

例えば写真のカラーカプラー 発色現像剤の組合せは感
度色素の安定性とも良好である。
For example, the combination of photographic color coupler and color developer has good stability of sensitivity dyes.

前記カプラーとしては特公昭63−37903号記載の
耐拡散性フェノール化合物、特公昭63−37904号
記載の耐拡散性ピラゾロン化合物等は特に好ましい。
As the coupler, diffusion-resistant phenol compounds described in Japanese Patent Publication No. 63-37903 and diffusion-resistant pyrazolone compounds described in Japanese Patent Publication No. 63-37904 are particularly preferred.

他に特開昭60−256056号(トリアリルメタンロ
イコ色素)、特開昭57−16697号(トリアリール
イミダゾリルロイコ色素)、特開昭59−193353
号(ジアリールイミダゾリルロイコ色素)に開示の色素
も利用可能である。(但しジアリールイミダゾリルロイ
コ色素は呈色安定性にかける。)これらは直接分散法又
はオイルプロテクト分数法等の公知の分散法で容易に分
散可能である。
In addition, JP-A-60-256056 (triallylmethane leuco dye), JP-A-57-16697 (triaryl imidazolyl leuco dye), JP-A-59-193353
(Diarylimidazolyl leuco dyes) can also be used. (However, diarylimidazolyl leuco dyes are subject to color stability.) These can be easily dispersed by a known dispersion method such as a direct dispersion method or an oil protect fraction method.

また一般に酵素免疫染色法や組織染色法に用いられる色
原体が使用可能である。その例としては、1)o−ジア
ニシジン又はその塩 2)o−トリジン又はその塩 3)3−アミノ−9−エチルカルバゾール4)ベンジジ
ン、 3.3’−ジアミノベンジジン、3.3’、5.
5’−テトラメチルベンジジン等のベンジジン誘導体又
はそれらの塩 5)4−アミノアンチピリン又はその誘導体又はそれら
の塩と、フェノール又はナフトール又はそれらの誘導体
との組合せ 6)4−クロル−1−ナフトール、4−アルコキシ−1
−ナフトール等のす7ト一ル誘導体 7)ロイコマカライ]・クリーン、ロイコフエ5ノール
フタレンのようなロイコ染料 等が挙げられる。
Furthermore, chromogens generally used in enzyme immunostaining methods and tissue staining methods can be used. Examples include 1) o-dianisidine or a salt thereof 2) o-tolidine or a salt thereof 3) 3-amino-9-ethylcarbazole 4) benzidine, 3.3'-diaminobenzidine, 3.3', 5.
Benzidine derivatives such as 5'-tetramethylbenzidine or salts thereof 5) Combination of 4-aminoantipyrine or derivatives thereof or salts thereof and phenol or naphthol or derivatives thereof 6) 4-chloro-1-naphthol, 4 -alkoxy-1
Examples include 7) tol derivatives such as naphthol, 7) leuco dyes such as leuco dyes such as leuco dyes such as leuco dyes such as 7) leuco dyes such as leuco dyes such as clean and leuco dyes.

また本発明においては還元系発色試薬としてテトラゾリ
ウム塩類(Tetrazolium 5alts)が好
ましくは適用され、 NT 3−(p−1odophenyl)−2−(p−nit
rophenyl)−5−pheny−2Htetra
zolium chlorideTT 3−(4,5−Dimethyl−2−thiazol
yl)−2,5−diphenyi28 tetraz
oliua+ bromideNeo−丁etrazo
lium   Blue、  Neo−TB(ネオテト
ラゾリウムブルー) 3 、3”(1、1’−Bipbenyi4 、4’−
diy 1)bis(2,5−d 1phenyl−2
1tetrazolium chloride)Nit
rotetrazolium BIue、Nitro−
TBにトロテトラゾリウムブルー) 3.3’−C3,3’−Dimethoxy−(1+ 
1’−biphenyl)−4,4’diyl)−bi
s(2−(p−nitrophenyl)−5−phe
nyl−2HtetrazoliuIIlchlori
de)TCtranitroLetrazoliuta
 Blue、TNTB(テトラニトロテトラゾリウムブ
ルー)3.3’−1:3.3’−Dimatboxy−
(l l 1’−biphenyl)−4,4’−di
yl−bis(2,5−bis(p−nitrophe
nyl)−2Htetrazolium chlori
de) TetrazoHutrr  Blue、丁B(テトラ
ゾリウムブルー) 3.3’−(3,3’−Dimethoxy−(1,l
’biphenyl)−4,4’−diyl)−bis
(2,5−diphenyl−2Htetrazoli
um  chloride) 等が例示される。
Further, in the present invention, tetrazolium salts (Tetrazolium 5 alts) are preferably applied as the reduction coloring reagent, and NT 3-(p-1odophenyl)-2-(p-nit
rophenyl)-5-pheny-2Htetra
zolium chlorideTT 3-(4,5-Dimethyl-2-thiazol
yl)-2,5-diphenyi28 tetraz
oliua+ bromideNeo-Dingetrazo
lium Blue, Neo-TB (neotetrazolium blue) 3,3” (1,1'-Bipbenyi4,4'-
diy 1) bis(2,5-d 1phenyl-2
1tetrazolium chloride)Nit
rotetrazolium BIue, Nitro-
Trotetrazolium blue in TB) 3.3'-C3,3'-Dimethoxy-(1+
1'-biphenyl)-4,4'diyl)-bi
s(2-(p-nitrophenyl)-5-phe
nyl-2HtetrazoliuIIlchlori
de)TCtranitroLetrazoliuta
Blue, TNTB (tetranitrotetrazolium blue) 3.3'-1:3.3'-Dimatboxy-
(l l 1'-biphenyl)-4,4'-di
yl-bis(2,5-bis(p-nitrophe)
nyl)-2Htetrazolium chlori
de) TetrazoHutrr Blue, Ding B (tetrazolium blue) 3.3'-(3,3'-Dimethoxy-(1,l
'biphenyl)-4,4'-diyl)-bis
(2,5-diphenyl-2Htetrazoli
um chloride), etc.

前記色原体の添加量は特に制約はないが(1,01〜1
.00a+ +wol/m’、好ましくは0.1−50
m s+ol/m”である。
There is no particular restriction on the amount of the chromogen added (1,01 to 1
.. 00a+ +wol/m', preferably 0.1-50
m s+ol/m".

更に反応連結を起動もしくは協同して発色反応を進める
作用素としては下記のものが例示される。
Furthermore, the following are exemplified as operators that activate or cooperate with the reaction linkage to advance the coloring reaction.

脱水素酵素系 コレステロールデヒドロゲナーズ グリセロール−3−燐酸デヒドロゲナーゼグリセロール
デヒドロゲナーゼ コリンオキシダーゼ(デヒドロゲナーゼとして【鎗く) 補酵素 NA、Dにコチンアミドジヌクレオシド)NADP に
コチンアミドジヌクレオシド燐酸)FAD (フラビン
アデニンジヌクレオシド)電子伝達剤 Meldola’s Blue (メルトラブル−)9
−Dimetbylavainobenzo−a −p
henazoxo旧umchloride ]−Methoxy PMS (1−メ トキシPMS
)1−Methoxy−5−methylphenaz
iniua+ methylsulfa仁e PMS ジアホラーゼ(酵素) これら作用素は解析すべき特定成分によって適宜使い分
けられる。
Dehydrogenase system Cholesterol dehydrogenase Glycerol-3-phosphate dehydrogenase Glycerol dehydrogenase Choline oxidase (as dehydrogenase) Coenzyme NA, cotinamide dinucleoside (D) NADP (cotinamide dinucleoside phosphate) FAD (flavin adenine dinucleoside) ) Electron transfer agent Meldola's Blue (Mel Trouble-) 9
-Dimetbylavainobenzo-a -p
henazoxo (formerly umchloride) -Methoxy PMS (1-methoxy PMS
)1-Methoxy-5-methylphenaz
iniua+ methylsulfa nitrile PMS diaphorase (enzyme) These operators are appropriately used depending on the specific component to be analyzed.

本発明の転写シートに係る支持体は、液不透性であれば
従来公知のものでよく、光透過性でも非透過性でもよい
。例えば酢酸セルロース、ポリエチレンテレフタレート
、ポリカーボネート、又はポリスチレン等の重合材料、
液不透処理を施した紙、繊維等の天然高分子材料、ガラ
スのごとき無機材料等が使用可能である。その厚さは任
意であるが好ましくは約50〜1000μmである。試
薬層を設ける支持体面に場合によっては下塗り層を使用
し、試薬層と支持体との接着性を改良する事も可能であ
る。
The support for the transfer sheet of the present invention may be any conventionally known support as long as it is liquid-impermeable, and may be either light-transmissive or non-transparent. polymeric materials such as cellulose acetate, polyethylene terephthalate, polycarbonate, or polystyrene;
Paper treated to make it impervious to liquid, natural polymeric materials such as fibers, inorganic materials such as glass, etc. can be used. Although its thickness is arbitrary, it is preferably about 50 to 1000 μm. It is also possible to improve the adhesion between the reagent layer and the support by using an undercoat layer in some cases on the support surface on which the reagent layer is provided.

本発明に係るシートの色素前駆体及び色素生成作用体を
含む層は親水性バインダから構成されるものであり、バ
インダとしてはゼラチン、フタル化ゼラチン等のゼラチ
ン誘導体、ヒドロキシエチルセルロース、カルボキシメ
チルセルロースナトリウム塩等の水溶性セルロース誘導
体、ポリビニルアル、コール、ポリアクリルアミド、ポ
リメタクリルアミド、ポリ(モノ又はジアルキル置換)
アクリルアミド、ポリ(モノ又はジアルキル置換)メタ
クリルアミド及びこれらの水溶性共重体等が挙げられる
The layer containing the dye precursor and dye-forming agent of the sheet according to the present invention is composed of a hydrophilic binder, and the binder includes gelatin, gelatin derivatives such as phthalated gelatin, hydroxyethyl cellulose, carboxymethyl cellulose sodium salt, etc. water-soluble cellulose derivatives, polyvinylalcohol, polyacrylamide, polymethacrylamide, poly(mono- or dialkyl-substituted)
Examples include acrylamide, poly(mono- or dialkyl-substituted) methacrylamide, and water-soluble copolymers thereof.

また転写シート最上層に少くとも目的特定成分を拡散可
能な物質に変換する酵素を含有する一層を設ける事も可
能である。この層のバインダはシートと目的特定成分を
固定化しt;支持体を接触させる際、酵素と特定成分を
効率よく接触させるため、ある程度の拡散性を与えるバ
インダが好ましくは前記親水性バインダのほかに繊維質
、多孔質、粒子結合構造等の層が挙げられる。
Furthermore, it is also possible to provide at least one layer containing an enzyme that converts the target specific component into a diffusible substance on the uppermost layer of the transfer sheet. The binder in this layer immobilizes the sheet and the target specific component; in order to bring the enzyme into contact with the specific component efficiently when the support is brought into contact, a binder that provides a certain degree of diffusivity is preferably used in addition to the hydrophilic binder described above. Examples include layers of fibrous, porous, particle-bound structures, and the like.

これらのシートの種々の層は、本発明に係る支持体上に
所望の構成に従い従来写真工業において公知のスライド
ホッパー塗布法、押出し塗布法、浸漬塗布法等を適宜選
択して用い、順次積層することで任意の厚みの層を塗設
する事ができる。
The various layers of these sheets are sequentially laminated on the support according to the present invention by appropriately selecting a slide hopper coating method, an extrusion coating method, a dip coating method, etc. conventionally known in the photographic industry according to the desired configuration. This allows a layer of arbitrary thickness to be applied.

〔実施例〕〔Example〕

本発明を具体的に実施例によって説明する。 The present invention will be specifically explained with reference to Examples.

実施例−I 脱イオン化ゼラチン        10g/m’P 
OD             5000U /ln”
フタル酸ジエチル        5.3g/Il+”
1−(2,4,6−トリクロルフェニル)−3−(2−
クロルオフダブシルスクシンイミドアニリノ)−5−ピ
ラゾロン      6.7g/a21.8M燐酸カリ
ウム 緩衝液(pl(7,2)38.0g/a’ アルカノールXC(デュポン社)  0.15g/+”
ビス(ビニルスルホニルメチル)エーテル0.36g/
m’ になるよう厚さ180μIの下塗り済、白色ポリエチレ
ンテレフタレート支持体上に塗布し、シート(1)とし
た。
Example-I Deionized gelatin 10g/m'P
OD 5000U/ln”
Diethyl phthalate 5.3g/Il+”
1-(2,4,6-trichlorophenyl)-3-(2-
Chloroffdabcylsuccinimideanilino)-5-pyrazolone 6.7g/a21.8M potassium phosphate buffer (pl(7,2)38.0g/a' Alkanol XC (Dupont) 0.15g/+"
Bis(vinylsulfonylmethyl)ether 0.36g/
It was coated onto a white polyethylene terephthalate support coated with an undercoat to a thickness of 180 .mu.m to give a sheet (1).

電気泳動用セルロースアセテート膜上に高脂血清(総コ
レステロール360mg/dQ、  トリグリセリド4
80+ag/dL ホスフォリピッド28Qtmg/d
Qであった。)の希釈系列を作成し、×1.0、×17
2、×l/4、XI/8を膜上にプロッティングした。
High lipid serum (total cholesterol 360 mg/dQ, triglyceride 4
80+ag/dL Phospholipid 28Qtmg/d
It was Q. ), create a dilution series of ×1.0, ×17
2, ×l/4, and XI/8 were plotted on the membrane.

反応液としてN、N−ジエチル−3−メタンスルホンア
ミドエチル−4−アミノアニリン・p−トルエンスルホ
ン酸50mMを含有する0、3M燐酸カリウム緩衝液に
下記の試薬の組を夫々添加して調製した。
A reaction solution was prepared by adding the following sets of reagents to a 0.3M potassium phosphate buffer containing 50mM of N,N-diethyl-3-methanesulfonamidoethyl-4-aminoaniline/p-toluenesulfonic acid. .

総コレステロール用 コレステロールオキシダーゼ   IU/++Qコレス
テロールエステラーゼ   IU/−1I2トリグリセ
ライド用 リポプロティンリパーゼ     O,?U /m(I
L−σ−グリセロホスフエートオギシダーゼ0.5U 
/raQ ホス7オリビツド用 * スホIJバーゼD         1.2U/m
i2コリンオキシダーゼ       0−3U 1m
Q本発明の転写シートへ上記反応液を含浸させた後、セ
ルロースアセテート膜と重ね合せ、37°C115分間
インキュベートした後、セルロースアセテート膜とシー
トを剥離し水洗した後乾燥し、コニカ光電濃度計P D
 A −65(コニカ(株)製)を用いて反射濃度を5
46Hのフィルタを使用測定した。
Cholesterol oxidase for total cholesterol IU/++Q cholesterol esterase IU/-1I2 Lipoprotein lipase for triglyceride O,? U/m(I
L-σ-glycerophosphate oxidase 0.5U
/raQ For Phos7 Oribit* Supho IJ Base D 1.2U/m
i2 choline oxidase 0-3U 1m
Q After impregnating the transfer sheet of the present invention with the above reaction solution, it was superimposed on a cellulose acetate film, incubated at 37°C for 115 minutes, and then the cellulose acetate film and sheet were peeled off, washed with water, dried, and then transferred to a Konica photodensitometer P. D
The reflection density was set to 5 using A-65 (manufactured by Konica Corporation).
Measurement was carried out using a 46H filter.

以上の如く良好な直線性を示した。As described above, good linearity was demonstrated.

実施例−2 厚さ約180μ国の透明なポリエチレンテレフタレート
支持体上に以下の組成の層を塗布した。
Example 2 A layer having the following composition was coated on a transparent polyethylene terephthalate support having a thickness of approximately 180 μm.

ゼラチン            10g/m”ジアホ
ラーゼ          60001J/m”3.3
’−(1,1’−ビスフェニル−4,47−ジイル)−
ビス(2,5−ジフェニル−2Hテトラゾリウムクロラ
イド)          23Qm moQ/m”T
rito口■X −100(ロームエントノ・−ス社)
0.3g/+o” ビス(ビニルスルホニルメチル)エーテル0.36g/
m2 このシートを本発明のシート(2)とした。
Gelatin 10g/m"Diaphorase 60001J/m"3.3
'-(1,1'-bisphenyl-4,47-diyl)-
Bis(2,5-diphenyl-2H tetrazolium chloride) 23Qm moQ/m”T
rito mouth ■X-100 (ROHM Entnos Co., Ltd.)
0.3g/+o” Bis(vinylsulfonylmethyl)ether 0.36g/
m2 This sheet was designated as the sheet (2) of the present invention.

更に0.3Mトリス塩酸緩衝液(pH−8,6)中にコ
レステロールエステラーテ0.3U/m12コレストロ
ールデヒドロゲナーデ 0−20U /a+Q N A D                    
   O,旧、moQ/mQになるように溶解した液を
用意し、更に実施例−1で用意した電気泳動用セルロー
スアセテ−1・膜に、同様に実施例−1で調整した高脂
血清をプロットした後上記酵素液を含浸し本発明のシー
ト(2)で重ね合せ37℃、15分間インキュベートし
、実施例−Iと同様に評価したところ良好な直線性を示
し tこ 。
Furthermore, cholesterol esterate 0.3U/ml in 0.3M Tris-HCl buffer (pH-8,6) 12 cholesterol dehydrogenade 0-20U/a+Q N A D
Prepare a solution dissolved to give moQ/mQ, and then add the high-fat serum prepared in Example-1 to the cellulose acetate-1 membrane for electrophoresis prepared in Example-1. After plotting, the sheet was impregnated with the enzyme solution and layered with the sheet (2) of the present invention, incubated at 37° C. for 15 minutes, and evaluated in the same manner as in Example-I, showing good linearity.

〔発明の効果〕〔Effect of the invention〕

本発明の方法は、従来の特定成分を固定化した支持体を
染色液中に浸漬して支持体上に発色パターンを出現させ
る方法と比べ、染色液の調整が不要、生成色素が安定シ
ートの機械的強度がすぐれ、パターンの長期保存が可能
、同じサンプルを用い種々の物質の解析が可能、染色液
に溶解不可能であった色票体が使用でき、感度の面で有
利であり、色調の選択の幅が大きくなる等の多大な利点
が示される。
The method of the present invention does not require adjustment of the staining solution, and the generated dye is transferred to the stabilizer sheet, compared to the conventional method of dipping a support on which a specific component is immobilized into a dyeing solution to create a colored pattern on the support. It has excellent mechanical strength, allows for long-term storage of patterns, allows the analysis of various substances using the same sample, allows the use of color strips that cannot be dissolved in staining solutions, is advantageous in terms of sensitivity, and has a wide range of color tones. There are many advantages such as a wider range of choices.

Claims (5)

【特許請求の範囲】[Claims] (1)電気泳動分画パターンを転写・記録するシステム
において、液不透性支持体上に、少なくとも色素前駆体
及び色素生成作用体を含む親水性コロイド層を少なくと
も1層設けた転写シート。
(1) In a system for transferring and recording electrophoretic fractionation patterns, a transfer sheet comprising at least one hydrophilic colloid layer containing at least a dye precursor and a dye-forming agent on a liquid-impermeable support.
(2)前記色素生成作用体が過酸化作用を呈する作用体
である請求項1に記載の転写シート。
(2) The transfer sheet according to claim 1, wherein the dye-forming agent is an agent exhibiting a peroxidizing effect.
(3)前記色素前駆体が過酸化水素の存在下で前記過酸
化作用を呈する作用体と協同して、単独または他の化合
物と共に色素を生成する化合物であることを特徴とする
請求項1または2に記載の転写シート。
(3) The dye precursor is a compound that produces a dye alone or together with other compounds in the presence of hydrogen peroxide in cooperation with the agent exhibiting a peroxidizing effect. 2. The transfer sheet described in 2.
(4)前記色素生成作用体が脱水素酵素を含むことを特
徴とする請求項1乃至3のいづれかに記載の転写シート
(4) The transfer sheet according to any one of claims 1 to 3, wherein the dye-forming agent contains a dehydrogenase.
(5)前記色素前駆体がテトラゾリウム塩であることを
特徴とする請求項1乃至4のいづれかに記載の転写シー
ト。
(5) The transfer sheet according to any one of claims 1 to 4, wherein the dye precursor is a tetrazolium salt.
JP63297721A 1988-11-24 1988-11-24 Transfer sheet for pattern of electrophoresis fractionation Pending JPH02143156A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP63297721A JPH02143156A (en) 1988-11-24 1988-11-24 Transfer sheet for pattern of electrophoresis fractionation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP63297721A JPH02143156A (en) 1988-11-24 1988-11-24 Transfer sheet for pattern of electrophoresis fractionation

Publications (1)

Publication Number Publication Date
JPH02143156A true JPH02143156A (en) 1990-06-01

Family

ID=17850316

Family Applications (1)

Application Number Title Priority Date Filing Date
JP63297721A Pending JPH02143156A (en) 1988-11-24 1988-11-24 Transfer sheet for pattern of electrophoresis fractionation

Country Status (1)

Country Link
JP (1) JPH02143156A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005305335A (en) * 2004-04-22 2005-11-04 Fulta Electric Machinery Co Ltd Mist separation mechanism of oil mist removal device

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005305335A (en) * 2004-04-22 2005-11-04 Fulta Electric Machinery Co Ltd Mist separation mechanism of oil mist removal device

Similar Documents

Publication Publication Date Title
EP0463524B1 (en) Composition and method of assaying for ketone bodies
GB1575947A (en) Analytical compositions and elements
JPS6348457A (en) Dry-type multi-layered analytical element
US5510245A (en) Composition and method of assaying for ketone bodies
JP2000262298A (en) Determination of glucose or cholesterol concentration in whole blood
JPH0721455B2 (en) Tools and Methods for Analyzing Specific Components in Liquid Samples
JPS61124393A (en) Analytic element for detection of hydrogen peroxide
JPH0527399B2 (en)
JPH02143156A (en) Transfer sheet for pattern of electrophoresis fractionation
US4567136A (en) Analytical element
JP3439836B2 (en) Apparatus and method for detecting a subject
JPH04638B2 (en)
JPH02208565A (en) Method and device for separating plasma from blood and analyzing element used for said method
JP2002369698A (en) Reagent for determining pyrophosphate
JP3167508B2 (en) Inorganic phosphorus determination reagent and dry analytical element
JP3704550B2 (en) Dry measurement test element
JPS6394994A (en) Dry analytical element containing oxidized form coenzyme and production thereof
JP2006087325A (en) Analytical reagent, dry analytical element and analytical method
JP4003993B2 (en) Method for producing dry analytical element and dry analytical element
USH600H (en) Whole blood analytical element and method of analyzing whole blood using the same
JP2564181B2 (en) Specific component analysis method
EP0464934B1 (en) Element for assay of catechol and catechol generating substances
JPS6017520B2 (en) Integrated element for triglyceride detection
JPH0671440B2 (en) Dry cholesterol analytical element
JP3639392B2 (en) Dry measurement test equipment